T1DM Immunotherapy Using Polyclonal Tregs + IL-2

Clinical trial NCT02772679 · COMPLETED

Trial details

NCT number: NCT02772679
Sponsor: Jeffrey Bluestone
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2016-08-01
Primary completion: 2021-08-27
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.